CanceroPedia
Cancer and oncology publisher with knowledge hubs and evidence-led news
CanceroPedia covers cancer as a lived, clinical, and public-health subject. We publish explainers, section indexes, and evidence-led news for readers trying to understand symptoms, screening, diagnosis, treatment, supportive care, and the long work of survivorship.
Our current architecture is built around two editorial taxonomies. The first is Cancer Types, a wide disease map that lets readers enter through a named diagnosis, subtype, or risk profile. The second is Knowledge, which brings together the action side of oncology: what cancer is, how testing works, how treatment language is used, what side effects matter, where palliative care fits, and how policy and research news change expectations.
We work from the assumption that readers do not arrive in a calm state. They often arrive after a symptom, a scan, a pathology report, a screening letter, an oncology appointment, or a frightening headline. That is why our writing is structured to move from plain explanation to practical next questions without losing complexity.
The publication has roots dating to 2011. The current edition expands that line into a broader publisher site with stronger editorial standards, clearer taxonomy, and a calmer reading experience modeled on the rhythm of serious medical publishing rather than generic health content.
Cancer Types
More than 300 type and subtype pages arranged as a navigable editorial map.
Knowledge
Core explainers on screening, diagnosis, testing, treatment, supportive care, survivorship, and evidence translation.
News Desk
Research-watch, approval-watch, conference coverage, and policy-driven updates that affect care conversations.
Breast cancer
Symptoms, risk factors, staging, treatment, recurrence, and survivorship.
Lung cancer
Screening, biomarker-aware care, pathology, and treatment classes.
Colorectal cancer
Early warning signs, screening routes, staging, and follow-up questions.
Prostate cancer
PSA, imaging, decision pathways, and quality-of-life implications.
Biomarker testing
A central bridge between diagnosis and treatment selection in modern oncology.
Liquid biopsy
What it can reveal, what it cannot replace, and why ctDNA matters.
Cancer fatigue
One of the most common and least well explained treatment burdens.
Fear of recurrence
A survivorship subject we treat as a core editorial beat.